Ascendia Pharmaceutical Solutions at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Ascendia Pharmaceutical Solutions brings 3 presentations to AAPS 2026 PharmSci 360 in New Orleans, and exhibits at Booth 1608. Its presence offers drug developers a partner for complex dosage forms, from formulation work through sterile and non-sterile production and lab testing.

OrganizationAAPS 2026 PharmSci 360 Attendance
CROs & CDMOs
Specialty CDMO for complex dosage forms, offering formulation development, sterile and non-sterile manufacturing and analytical services.
Booth
Exhibiting at Booth 1608
Mon, Oct 268:30am–5:00pmTue, Oct 278:30am–5:00pmWed, Oct 288:30am–1:30pm
Talk
Mon Oct 26
3:10pm–3:30pm
Part of Excipient Quality in Complex Generics
Panel Discussion and Q&A
USP Spotlight Stage, Exhibit Hall
Excipient Quality in Complex Generics · with Teva, USP, Pfizer
Talk
Mon Oct 26
4:30pm–4:55pm
Part of Development of Excipient Composition General Chapter <1068>
Panel Discussion and Q&A
USP Spotlight Stage, Exhibit Hall
Excipient Quality in Complex Generics · with USP, Creekmore Pharma Consulting, Lubrizol
Talk
Tue Oct 27
4:15pm–4:45pm
Part of USP Emerging Standards
Panel Discussion and Q&A
USP Spotlight Stage, Exhibit Hall
USP Emerging Standards · with USP, Drug Development Consultants, Creekmore Pharma Consulting +1 more

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Ascendia Pharmaceutical Solutions

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction